NCT05511090

Brief Summary

Based on the previous review and research, we would like to further observe the nodule changes in patients with pulmonary nodules. These changes include factors such as the reason for the further enlargement or deterioration of the nodule, time, lifestyle, the patient's region, and hereditary medical history. At the same time, we will further look at the corresponding characteristics of a population that does not change the size and nature of the nodule, including age, gender, and all the factors discussed above. On this basis, we can propose more scientific methods for the treatment and management of pulmonary nodules, and provide a more reliable clinical reference for the clinical treatment of pulmonary nodules.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2022

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 19, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 22, 2022

Completed
8 days until next milestone

Study Start

First participant enrolled

August 30, 2022

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2023

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2023

Completed
Last Updated

August 22, 2022

Status Verified

August 1, 2022

Enrollment Period

11 months

First QC Date

August 19, 2022

Last Update Submit

August 19, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in nodule size by CT scan in patients with pulmonary nodules during follow-up.

    Changes in nodule size by CT scan in patients with pulmonary nodules during follow-up.

    6 months

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

LNs patients aged 18 years and older who were previously treated in Guang'anmen hospital.

You may qualify if:

  • LNs patients aged 18 years and older who were previously treated in Guang'anmen hospital.

You may not qualify if:

  • (1) had the LNs removed; (2) LNs less than or equal to 3 mm in size; (3) had not undergone thorax CT; (4) had failed to complete treatment; (5) had incomplete medical records or was lost to follow-up.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
NETWORK
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 19, 2022

First Posted

August 22, 2022

Study Start

August 30, 2022

Primary Completion

August 1, 2023

Study Completion

December 31, 2023

Last Updated

August 22, 2022

Record last verified: 2022-08